Sahajanand Medical Technologies IPO GMP Today

The issue

Sahajanand Medical Technologies Limited is an Indian medical devices company that designs, develops, manufactures, and markets products for vascular and structural heart interventions. Its portfolio includes coronary stents, balloons, transcatheter aortic valve implantation (TAVI) systems, occluders, renal stents, and peripheral drug-coated balloons. The company operates manufacturing facilities in India and Thailand and distributes its products across more than 70 countries globally.

Sahajanand Medical Technologies Limited is a Mainboard issue on NSE & BSE. The price band is ₹327–₹344. One lot is 43 shares, and the smallest application is 1 lot (43 shares, ₹14,792 at the top of the band). The issue size is ₹475.48 crore.

The public offer is entirely an offer for sale of ₹475.48 crore by selling shareholders, meaning the company will not receive any proceeds from the issue. The issue aims to achieve the benefits of listing the equity shares on the stock exchanges.

For FY26, the company reported consolidated revenue from operations of ₹1,210.50 crore, an increase of 18.1% from ₹1,024.88 crore in FY25. Profit after tax surged 174.6% to ₹69.08 crore in FY26 compared to ₹25.15 crore in FY25.

Sahajanand Medical Technologies listed on 23 Oct 2026 at +7.89% over the ₹344 issue price. The last grey-market premium before listing was +₹17 (+4.94%), so the listing came in above what the grey market implied.

Latest overall subscription on this edition is 14.20×. A multiple above 1.00× means applications for more shares than are on offer; it does not mean you will get shares. Retail allotment in an oversubscribed category is a lottery for one lot. The split across QIB, NII and retail is omitted unless it belongs to the same snapshot as this total.

The company operates in a strictly regulated medical device sector where product approvals and CE certifications can be time-consuming and expensive. It also incurred a consolidated net loss of ₹7.35 crore in FY24, alongside past standalone losses, with no assurance that losses will not recur.

The timetable on the record is open 15 Oct 2026, close 19 Oct 2026, allotment 21 Oct 2026, listing 23 Oct 2026. MUFG Intime India is the registrar. Check allotment on their site with your PAN after the basis is out. After listing, this page stays up. The grey-market mark becomes history, and the listing print replaces the expected-listing sketch. Do not apply because a premium looks large. Read the prospectus.

Company profile: AI analysis of the offer document and news coverage (2 Nov 2026). Sources: m.economictimes.com, angelone.in, tradingview.com, trendlyne.com, biospectrumindia.com. Check the offer document before relying on a figure.